What is Retinoblastoma?

Childhood Cancer, Common Types, Featured Blogs, Rally Blog, Research, What Is

What is Retinoblastoma? In simple terms, retinoblastoma is an eye cancer that develops in the immature cells of the retina. Though it is rare—with approximately 300 children diagnosed in the U.S. each year—it is the most common eye cancer in children. This malignant...

What is Wilms Tumor?

Childhood Cancer, Common Types, Featured Blogs, Rally Blog, Research, What Is

What is Wilms Tumor? Wilms tumor is a type of kidney cancer that primarily develops in children around the ages of three and four. It’s the most common type of kidney cancer found in kids. Approximately 9 out of 10 kidney cancers in children are Wilms tumors,...

Turning Early Funding Into Lifesaving Discoveries: Dr. Anthony Faber’s Neuroblastoma Breakthroughs

Rally-Funded Discoveries

Turning Early Funding Into Lifesaving Discoveries: Dr. Anthony Faber’s Neuroblastoma Breakthroughs What if $100,000 could unlock $3.5 million and help bring new treatments to kids with cancer?  That’s exactly what happened with Anthony Faber, Ph.D., a researcher at...

Why Early Research Matters: Rally’s Role in Advancing Neuroblastoma Care

Rally-Funded Discoveries

Why Early Research Matters: Rally’s Role in Advancing Neuroblastoma Care In 2020 and 2023, Smita Matkar, Ph.D., at the Children’s Hospital of Philadelphia (CHOP) received early research funding from Rally Foundation for Childhood Cancer Research. That support...

A Bold Idea, Backed Early: Rally’s Role in Advancing Leukemia Research

Rally-Funded Discoveries

A Bold Idea, Backed Early: Rally’s Role in Advancing Leukemia Research In 2016, Kimberly Stegmaier, M.D., at the Dana-Farber Cancer Institute received early research funding from Rally Foundation for Childhood Cancer Research. That support allowed her team to explore...

Name:

Category:

Type: